新闻资讯

Toripalimab as 1st-Line Treatment for NPC Approved in China

11-29
2021
Junshi Biosciences Announce Toripalimab Granted ODD in the US for EC

11-16
2021
TopAlliance Appoints Virginia Ellen Maher, MD, as Vice President of Medical Sciences

11-01
2021
US FDA Accepted BLA Filing for Toripalimab for Treatment of NPC

10-31
2021

More

//